These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 3084343)
21. Pharmacology, clinical efficacy, and adverse effects of sucralfate, a nonsystemic agent for peptic ulcer. Spiro HM Pharmacotherapy; 1982; 2(2):67-71. PubMed ID: 6927335 [TBL] [Abstract][Full Text] [Related]
22. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy. Jones DB; Hunt RH Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708 [No Abstract] [Full Text] [Related]
24. The other option in peptic ulcer therapy. Halter F S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932 [TBL] [Abstract][Full Text] [Related]
25. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1984 Mar; 27(3):194-209. PubMed ID: 6368184 [TBL] [Abstract][Full Text] [Related]
26. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate. Bianchi Porro G; Parente F J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753 [TBL] [Abstract][Full Text] [Related]
27. Drugs for treatment of peptic ulcers. Dajani EZ; Trotman BW J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999 [TBL] [Abstract][Full Text] [Related]
29. Pharmacology of the treatment of peptic ulcer disease. Bertaccini G; Coruzzi G Dig Dis Sci; 1985 Nov; 30(11 Suppl):43S-51S. PubMed ID: 2865092 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacologic treatment of ulcers]. Honorato Pérez J; Azanza Perea JR; Cuena Boy R Rev Med Univ Navarra; 1984 Jun; 28(2):53-8. PubMed ID: 6149611 [No Abstract] [Full Text] [Related]
31. Stress ulcers--prevention of gastrointestinal bleeding in critical care units. Bank S Med J Aust; 1985 Feb; 142 Spec No():S17-20. PubMed ID: 2869398 [No Abstract] [Full Text] [Related]
32. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study. Pop P; Nikkels RE; Thys O; Dorrestein GC Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320 [TBL] [Abstract][Full Text] [Related]
35. Cytoprotective and ulcer healing properties of prostaglandin E2, colloidal bismuth and sucralfate in rats. Konturek SJ; Stachura J; Radecki T; Drozdowicz D; Brzozowski T Digestion; 1987; 38(2):103-13. PubMed ID: 3126091 [TBL] [Abstract][Full Text] [Related]
36. Binding of sucralfate to duodenal ulcer in man. Sasaki H; Hinohara Y; Tsunoda Y; Nagashima R Scand J Gastroenterol Suppl; 1983; 83():13-4. PubMed ID: 6579630 [TBL] [Abstract][Full Text] [Related]
37. The mode of action of colloidal bismuth subcitrate. Lee SP Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120 [TBL] [Abstract][Full Text] [Related]
38. Sucralfate compared with ranitidine in the short-term healing of duodenal ulcers. Lam KT; Lai ST; Kan YS; Chan AY J Int Med Res; 1985; 13(6):338-41. PubMed ID: 3841079 [TBL] [Abstract][Full Text] [Related]
39. Sucralfate--a new drug for duodenal ulcer. Med Lett Drugs Ther; 1982 Jan; 24(600):2-3. PubMed ID: 7033749 [No Abstract] [Full Text] [Related]
40. Protective drugs in the treatment of gastroduodenal ulcer disease. Koelz HR Scand J Gastroenterol Suppl; 1986; 125():156-64. PubMed ID: 3547612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]